Hepatitis C virus inhibitors

Details for Australian Patent Application No. 2010319801 (hide)

Owner Bristol-Myers Squibb Company

Inventors Lavoie, Rico; Bender, John A.; Yang, Zhong; Belema, Makonen; Lopez, Omar D.; Chen, Qi; Wang, Gan; Hewawasam, Piyasena

Agent A J Park

Pub. Number AU-A-2010319801

PCT Pub. Number WO2011/059887

Priority 61/260,115 11.11.09 US; 61/378,806 31.08.10 US

Filing date 5 November 2010

Wipo publication date 19 May 2011

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

28 June 2012 PCT application entered the National Phase

  PCT publication WO2011/059887 Priority application(s): WO2011/059887

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010319820-Method and system for independent control of vehicles

2010319792-Olefin feed purification process